Empal, Loreto P.
HRN: 26-38-37 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/15/2024
12/21/2024
IV
500mg
Q8H
T/c Ileus Vs Intestinal Obstruction Cannot R/O Abdominal Mass
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes